TP53 and head and neck squamous cell carcinoma: p16, EGFR and p53 positivity was noted in 22.1%, 18.8%, and 66.2% cases, respectively, whereas loss of p27 expression was seen in 14.3% cases of HNSCC, as shown in Table 1.